Milking Cancer
Eli Lilly is now the sole manufacturer of rBGH — the artificial growth hormone given to dairy cows that increases people’s risk of cancer. Eli Lilly also manufactures breast cancer treatment medications and a pill that “reduces the risk” of breast cancer. Eli Lilly is milking cancer. Tell them to stop making rBGH.
Source
OLD MUSCLE MADE YOUNG WITH SC
“Our study shows that the ability of old human muscle to be maintained and repaired by muscle stem cells can be restored to youthful vigor”
Clues To Reversing Aging Of Human Muscle Discovered
ScienceDaily (Sep. 30, 2009) — A study led by researchers at the University of California, Berkeley, has identified critical biochemical pathways linked to the [...]
Source
STEM CELL DEBATE – 2001
Stem Cell Debate – 2001 – A blast from the past
Steve Carell would rather debate over Dutch prostitutes than stem cell research.

Source
Stem cell hope for childhood motor neuron disease – health – 22 September 2009 – New Scientist
Stem cell hope for childhood motor neuron disease
* 22:00 22 September 2009 by Andy Coghlan
A form of motor neuron disease that affects children has been treated in mice with injections of stem cells into the spinal cord. The treatment extended the lives of the mice beyond and kept them more mobile, giving hope that similar [...]
Source
Stem Cell Stock Analysis
WHAT ARE ALL OF THE STEM CELL STOCKS DOING?
To see a REAL TIME list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS – REAL TIME
To see a DAY WATCH list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS – DAY WATCH
To see a BASIC list of these stocks on [...]
Source
U. expert to lead stem cell research panel
University of Utah medical ethics expert Jeffrey R. Botkin has been named chairman of a new nine-member group that will act as a clearinghouse for science research project requests for embryonic stem cells.
Source
Excellent SC Mobilization + Safety Profile for TG-0054
TaiGen Biotechnology Co., Ltd. announced today that in a phase 1 study in healthy volunteers TG-0054, a chemokine receptor CXCR4 antagonist, was well tolerated and rapidly mobilized stem cells and endothelial progenitor cells from bone marrow into peripheral blood.
Source
TOP OTC STOCK PICKS
Stem Cell Therapy International, Inc., through its wholly owned subsidiary, Stem Cell Therapy International Corp., engages in licensing of stem cell technology and the sale of stem cell products, as well as the provision of information, education, and referral services.
Source
Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma
Browse > Home / Hodgkin’s Lymphoma, News, Progressive Relapsed Hodgkin’s Lymphoma / Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma
Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma
September 24, 2009
Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the [...]
Source
NIH EXPANDS SC RESEARCH FUNDING
The National Institutes of Health moved closer today to fulfilling President Obama’s pledge to expand the number of stem cell lines eligible for use in federally funded research projects.
Source
Related Blogs
- Related Blogs on NIH EXPANDS SC RESEARCH FUNDING
Excellent Stem Cell Mobilization and Safety Profile for TG-0054
In Taiwan:
TaiGen Biotechnology Co., Ltd. announced today that in a phase 1 study in healthy volunteers TG-0054, a chemokine receptor CXCR4 antagonist, was well tolerated and rapidly mobilized stem cells and endothelial progenitor cells from bone marrow into peripheral blood. The number of CD34+ stem cells in circulation after one dose of TG-0054 was equal or higher than reported cell numbers needed for stem cell transplantation in cancer patients. The observed AEs were all mild and transient. A phase 2 study in stem cell transplantation for multiple myeloma,
…
Boys born with cerebral palsy make steady improvement after autologous stem cell therapy
The Denver Post caught up with two fifth-grade boys and their families who spent their summer in Germany. The trip was no cultural excursion, or sightseeing adventure - it was medical tourism. Born with cerebral palsy, best friends Dominic King and Harrison Spiers visited a European stem cell treatment center where each received injections of their own stem cells. Already the parents have observed progress in both boys.
Looking up now
A slow-motion ballet
…



